Jessica Hopfield, Director at Editas Medicine, Inc. (EDIT), bought 5,800 shares at $45.51 ($264K) on 2021-03-03, disclosed to the SEC on 2021-03-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EDIT | BUY | 2024-05-14 | $254K | — | Filing → |
| BLI | BUY | 2022-03-11 | $502K | — | Filing → |
| MRVI | BUY | 2020-11-25 | $1.4M | — | Filing → |